Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales. Merck’s immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
Your trusted source for real-time market insights, expert analysis, and breaking financial news. We deliver actionable updates on global markets, stocks, crypto, and economic trends empowering investors to make informed decisions every day.
Contact us: contact@financeworld-news.com
© Copyright 2025 - financeworld-news.com